PPFlow: Target-aware Peptide Design with Torsional Flow Matching
Therapeutic peptides have proven to have great pharmaceutical value and potential in recent decades. However, methods of AI-assisted peptide drug discovery are not fully explored. To fill the gap, we propose a target-aware peptide design method called \textsc{PPFlow}, based on conditional flow matching on torus manifolds, to model the internal geometries of torsion angles for the peptide structure design. Besides, we establish a protein-peptide binding dataset named PPBench2024 to fill the void of massive data for the task of structure-based peptide drug design and to allow the training of deep learning methods. Extensive experiments show that PPFlow reaches state-of-the-art performance in tasks of peptide drug generation and optimization in comparison with baseline models, and can be generalized to other tasks including docking and side-chain packing.
Code (1)
Tasks
Drug DesignDrug DiscoverySimilar Papers 제목 키워드 기반
APCyc: Property-Informed Design of Cyclic Peptides via Automated Cyclization
Cyclic peptides represent a promising class of therapeutic compounds in modern drug discovery, often offering improved stability and binding affinity. However, the de novo design of cyclic peptides remains challenging be…
Drug DiscoveryFAR-DPO: Feasibility-Aware and Robust Direct Preference Optimization for Cyclic Peptide Design
Cyclic peptides are emerging as promising molecular scaffolds in drug discovery due to their high binding affinity and structural stability. However, extending generative models from linear to cyclic peptide design remai…
Drug DiscoveryPepti-drift: Toxicity-Repulsive Drifting for Antigen-Conditioned Discrete Peptide Generation
Peptides are a promising therapeutic modality that combine the chemical tunability of small molecules with the target specificity of macromolecular therapeutics. However, designing antigen-specific binding peptides while…
Target-Specific De Novo Peptide Binder Design with DiffPepBuilder
Despite the exciting progress in target-specific de novo protein binder design, peptide binder design remains challenging due to the flexibility of peptide structures and the scarcity of protein-peptide complex structure…
Hotspot-Driven Peptide Design via Multi-Fragment Autoregressive Extension
Peptides, short chains of amino acids, interact with target proteins, making them a unique class of protein-based therapeutics for treating human diseases. Recently, deep generative models have shown great promise in pep…